Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Phase 1

Active, not recruiting

Conditions: Clonal Cytopenia of Undetermined Significance
CCUS Clonal Cytopenia of Undetermined Significance

Interventions: Drug: Enasidenib

First Posted Date: 2021-11-01

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT05102370

Locations: 🇺🇸
Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

and more 9 locations

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Biological: Androgen deprivation therapy (ADT)
Radiation: Brachytherapy
Radiation: Hypofractionated pelvic External beam radiation

First Posted Date: 2021-10-29

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT05100472

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Early Phase 1

Recruiting

Conditions: Histiocytic Neoplasms
Non-Hodgkin Lymphoma
Multiple Myeloma
Rosai-Dorfman Disease
Erdheim-Chester Disease

Interventions: Drug: [68Ga]-Pentixafor

First Posted Date: 2021-10-26

Last Posted Date: 2025-04-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT05093335

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

Phase 2

Active, not recruiting

Conditions: Breast Cancer
Breast Cancer Stage IV
Metastatic Breast Cancer

Interventions: Dietary Supplement: Low Carbohydrate Diet
Dietary Supplement: Ketogenic Diet
Drug: Alpelisib
Drug: Fulvestrant
Drug: Canagliflozin

First Posted Date: 2021-10-22

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT05090358

Locations: 🇺🇸
Ohio State University (Data Collection & Data Analysis), Columbus, Ohio, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 6 locations

A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma

Phase 1

Active, not recruiting

Conditions: Lymphoma

Interventions: Drug: N-Acetylcysteine

First Posted Date: 2021-10-18

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT05081479

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer

Phase 1

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: 177Lu-PSMA-617
Procedure: Stereotactic Body Radiotherapy (SBRT)

First Posted Date: 2021-10-15

Last Posted Date: 2025-01-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 27

Registration Number: NCT05079698

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Near-Infrared Fluorescence Imaging With ICG During Reconstructive Gynecologic Surgery

Not Applicable

Active, not recruiting

Conditions: Gynecologic Surgery

Interventions: Diagnostic Test: ICG-NIR angiography

First Posted Date: 2021-10-08

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 15

Registration Number: NCT05071976

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and Followup), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent and Followup), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent and Followup), Middletown, New Jersey, United States

and more 4 locations

A Study of Pembrolizumab and Cryoablation in People With Mesothelioma

Phase 1

Completed

Conditions: Lung Cancer
Unresectable Mesothelioma

Interventions: Drug: Pembrolizumab
Procedure: Image-guided cryoablation

First Posted Date: 2021-10-07

Last Posted Date: 2023-12-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2

Registration Number: NCT05071014

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited protocol activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All protocol activities), New York, New York, United States

and more 4 locations

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Conditions: Central Nervous System/Leptomeningeal Neoplasms

First Posted Date: 2021-10-01

Last Posted Date: 2025-03-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT05064306

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

Phase 1

Completed

Conditions: Breast Cancer
HER2-negative Breast Cancer
MEK1 Gene Mutation
Metastatic Breast Cancer
Breast Cancer Stage IV
MEK2 Gene Mutation
Solid Carcinoma

Interventions: Drug: Mirdametinib
Drug: Fulvestrant

First Posted Date: 2021-09-23

Last Posted Date: 2025-05-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT05054374

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy